CRSP Operating Cash Flow Growth
Crispr Therapeutics Ag · Operating Cash Flow Growth
CRSP Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-13.80%period ending
CRSP TTM Cash from Operations YoY % (-193.07% → -13.80%)
Year-over-year change
High-resolution chart · PNG
CRSP operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -13.7977% | |
| -30.5055% | |
| -141.6504% | |
| -60.2046% | |
| -166.7326% | |
| -92.2401% | |
| 45.166% | |
| 31.9901% | |
| 64.5009% | |
| 54.6714% | |
| 47.4776% | |
| 40.7345% | |
| 22.8472% | |
| -169.7276% | |
| -191.979% | |
| -186.1443% | |
| -180.9138% | |
| 275.8372% | |
| 326.1111% | |
| 453.6254% | |
| 892.7849% | |
| -694.6516% | |
| -520.5692% | |
| -716.8639% | |
| 143.0828% | |
| 141.1287% | |
| 158.8919% | |
| 130.1406% | |
| -63.4017% | |
| -69.0687% | |
| -37.294% | |
| -10.7646% | |
| -10.5995% | |
| -0.9679% | |
| -26.7348% | |
| -325.524% | |
| -277.3738% | |
| -234.7295% | |
| -193.0706% |